Stock listing
NRSN Stock Price, News, Filings & Events — Neurosense Therapeutics Ltd.
Selected listing: NRSN · NASDAQ · USD · US
This page tracks Neurosense Therapeutics Ltd.'s NRSN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NRSN:NASDAQ. NRSN:NASDAQ is the stock-level entry point for investors researching Neurosense Therapeutics Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neurosense Therapeutics Ltd. (NRSN) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- NRSN:NASDAQ
- Asset type
- Stock
- Market cap
- $13.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Neurosense Therapeutics Ltd. NRSN:NASDAQ stock context
This page tracks Neurosense Therapeutics Ltd.'s NRSN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NRSN:NASDAQ. NRSN:NASDAQ is the stock-level entry point for investors researching Neurosense Therapeutics Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neurosense Therapeutics Ltd. (NRSN) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Neurosense Therapeutics Ltd.
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
August 31, 2026
NeuroSense Issues CEO Letter to Shareholders
August 13, 2026
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
July 22, 2026
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
July 6, 2026
Research Neurosense Therapeutics Ltd.
Neurosense Therapeutics Ltd. investor report
Review AI stock analysis and investor report context for NRSN:NASDAQ.
Neurosense Therapeutics Ltd. company profile
View the public company page for Neurosense Therapeutics Ltd. on 6ix.
Neurosense Therapeutics Ltd. news
Read company news and market updates connected to Neurosense Therapeutics Ltd..
Neurosense Therapeutics Ltd. investor events
Find investor webinars, events, and replay context for Neurosense Therapeutics Ltd..